Evidence map›Paper›PMID 28970902›Full record

ArticleChemical science2017

Double quick, double click reversible peptide "stapling".

Claire M Grison, George M Burslem, Jennifer A Miles, Ludwig K A Pilsl, David J Yeo, Zeynab Imani, Stuart L Warriner, Michael E Webb, Andrew J Wilson

Abstract read
In one paragraph

Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Constraining and Modifying Peptides Using Pd-Mediated Cysteine Allylation.Chembiochem : a European journal of chemical biology · 2023
    Article
  8. Rational design of Harakiri (HRK)-derived constrained peptides as BCL-xChemical communications (Cambridge, England) · 2023
    Article
  9. Article
  10. How to Design Peptides.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  11. Article
  12. Anticancer Activity of Reconstituted Ribonuclease S-Decorated Artificial Viral Capsid.Chembiochem : a European journal of chemical biology · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Semisynthesis of Human Ribonuclease-S.Bioconjugate chemistry · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claire M GrisonSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.ORCID 0000-0002-3179-2093
George M BurslemSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.ORCID 0000-0002-2812-983X
Jennifer A MilesSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.ORCID 0000-0001-8839-9201
Ludwig K A PilslSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.
David J YeoSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.
Zeynab ImaniSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.
Stuart L WarrinerSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.ORCID 0000-0002-7589-6011
Michael E WebbSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.ORCID 0000-0003-3574-4686
Andrew J WilsonSchool of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK . Email: A.J.Wilson@leeds.ac.uk.ORCID 0000-0001-9852-6366

Funding

European Research Council 240324Wellcome Trust
6 · The paper itself

Abstract

The development of constrained peptides for inhibition of protein-protein interactions is an emerging strategy in chemical biology and drug discovery. This manuscript introduces a versatile, rapid and reversible approach to constrain peptides in a bioactive helical conformation using BID and RNase S peptides as models. Dibromomaleimide is used to constrain BID and RNase S peptide sequence variants bearing cysteine (Cys) or homocysteine (

Identifiers

PMID28970902
PMCPMC5618791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.